- Corporate Officers - N
- Neels Guido J
Insider Trading History of Neels Guido J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Neels Guido J since 2015.
This trader's CIK number is 1222362.
At the time of last reporting, Neels Guido J was the Officer of Axogen, Inc.. (stock ticker symbol AXGN).
Also see all insider trading activities at Axogen, Inc..
Note that in the past
NEELS GUIDO J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Entellus Medical Inc (ENTL) by Neels Guido J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | ENTL | 15,000 | $255,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Axogen, Inc. (AXGN) by Neels Guido J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | AXGN | 0 | $0 | 4,073 | $43,214 | 0 | $0 |
2024 | AXGN | 0 | $0 | 0 | $0 | 11,904 | $0 |
2023 | AXGN | 10,000 | $61,100 | 0 | $0 | 6,459 | $0 |
2022 | AXGN | 0 | $0 | 0 | $0 | 6,072 | $0 |
2021 | AXGN | 0 | $0 | 0 | $0 | 6,173 | $0 |
2017 | AXGN | 0 | $0 | 1,150,000 | $22,701,000 | 0 | $0 |
Yearly summary of insider trading at Endologix Inc /de/ (ELGX) by Neels Guido J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | ELGX | 22,692 | $149,994 | 0 | $0 | 0 | $0 |
2017 | ELGX | 20,000 | $86,400 | 0 | $0 | 0 | $0 |
2016 | ELGX | 13,000 | $99,970 | 0 | $0 | 0 | $0 |
2015 | ELGX | 11,000 | $102,520 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bioventus Inc. (BVS) by Neels Guido J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | BVS | 0 | $0 | 0 | $0 | 26,493 | $0 |
2024 | BVS | 0 | $0 | 0 | $0 | 30,400 | $0 |
2023 | BVS | 0 | $0 | 0 | $0 | 16,648 | $0 |
2022 | BVS | 0 | $0 | 0 | $0 | 11,700 | $0 |
Insider trading activities at 4 companies by Neels Guido J:
1. Entellus Medical Inc (ENTL)
2. Axogen, Inc. (AXGN)
3. Endologix Inc /de/ (ELGX)
4. Bioventus Inc. (BVS)
Table 1. Insider trading of Entellus Medical Inc (ENTL) by Neels Guido J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-02-03 | ENTL | Buy | 15,000 | 17.00 | 255,000 |
Table 2. Insider trading of Axogen, Inc. (AXGN) by Neels Guido J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-06-09 | AXGN | Sale | 4,073 | 10.61 | 43,214 |
2024-09-01 | AXGN | Option Ex | 11,904 | .00 | 0 |
2023-08-16 | AXGN | Buy | 10,000 | 6.11 | 61,100 |
2023-06-01 | AXGN | Option Ex | 6,459 | .00 | 0 |
2022-06-01 | AXGN | Option Ex | 3,036 | .00 | 0 |
2022-06-01 | AXGN | Option Ex | 3,036 | .00 | 0 |
2021-06-01 | AXGN | Option Ex | 6,173 | .00 | 0 |
2017-11-20 | AXGN | Sale | 1,150,000 | 19.74 | 22,701,000 |
Table 3. Insider trading of Endologix Inc /de/ (ELGX) by Neels Guido J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-04-03 | ELGX | Buy | 22,692 | 6.61 | 149,994 |
2017-05-19 | ELGX | Buy | 20,000 | 4.32 | 86,400 |
2016-11-18 | ELGX | Buy | 13,000 | 7.69 | 99,970 |
2015-11-03 | ELGX | Buy | 11,000 | 9.32 | 102,520 |
Table 4. Insider trading of Bioventus Inc. (BVS) by Neels Guido J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-06-02 | BVS | Option Ex | 26,493 | .00 | 0 |
2024-06-07 | BVS | Option Ex | 30,400 | .00 | 0 |
2023-06-06 | BVS | Option Ex | 16,648 | .00 | 0 |
2022-04-01 | BVS | Option Ex | 2,700 | .00 | 0 |
2022-02-11 | BVS | Option Ex | 9,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Neels Guido J
(Officer of Axogen, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.